ZBH

ACCE-researched
Zimmer Biomet Holdings Inc. Common Stock
Healthcare · Medical Devices · NYSE · United States
$95.36+1.18%
Market cap $18.2BNext earnings 2026-11-04Updated Sep 19, 2026
FAIR VALUE · CONSENSUS
$95.36+0.0%
confidence-weighted across 4 of 6 models
Now $95.36
$95.36
$48.97$201.26
HoldBronze54
Price vs fair value
0.7% below
+0.7% to fair value
ACCE score
68
out of 100
Analysts
38% buy
29 covering
P/E
23.1x
forward 10.5x
1-year return
-4.8%
Dividend yield
1.02%
Unlock the ACCE read
INVESTOR

Overview

Reports in 44 days, last quarter beat by 0.0%.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Price

-6.3% · 1Y

Valuation

INVESTOR
Full valuation engine INVESTOR FEATURE

Six independent models converge on one confidence-weighted fair value, with full methodology and editable assumptions.

  • +All six models: DCF, P/E and EV/EBITDA comps, Graham, dividend discount, residual income
  • +Scenario bands, sensitivity tornado, and the 5-year historical valuation range
  • +Editable DCF workbench with saved scenarios

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: conviction breakdown, earnings quality, score history, and backtested returns.

  • +Conviction score breakdown and earnings-quality grade
  • +Growth / value / quality / momentum component scores
  • +90-day score history and score-threshold backtests

Analysts

Wall Street consensus

Bearish38% buy · 29 covering analysts
● Strong buy 5● Buy 6● Hold 16● Sell 1● Strong sell 1
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO
Smart money tracking PRO FEATURE

Follow the institutions: 13F position changes, insider trades, and active 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Recent open-market insider transactions
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

This stock Peer Peer median weaker → stronger
P/Ebetter than 50% of peers
low 18.7x23.1xhigh 78.0x
ROEbetter than 0% of peers
low 6%6%high 12%
Div yieldbetter than 17% of peers
low 0.0%1.0%high 4.1%

Algorithmic peers (6)

TickerCompanyMcapP/EROED/EYieldQuality
STESTERIS plc (Ireland) Ordinary Shares$20.0B25.111.4%0.271.2%-Compare
4543.TTerumo$20.9B24.310.9%26.361.6%-Compare
PHGKoninklijke Philips N.V. NY Registry Shares$24.1B18.810.2%0.714.1%-Compare
PHIA.ASKoninklijke Philips$24.2B18.910.2%0.624.0%-Compare
PENPenumbra Inc. Common Stock$12.5B78.011.4%0.010.0%-Compare
SNNSmith & Nephew SNATS Inc. Common Stock$11.5B18.711.8%0.592.9%-Compare

Sector report card

Where ZBH ranks against its sector peers on each metric.

Computing percentiles…

News and Record

Reports in 44 days, last quarter beat by 0.0%.

Press releases mentioning this company

Ask anything, Pro feature

Ask questions about this stock in plain language. Answered from company fundamentals + recent valuations.

PRO

Recent performance

1 week
+2.0%
1 month
-5.3%
3 months
+8.4%
6 months
+8.5%
YTD
+6.0%
1 year
-4.8%

SEC filings

40 filings
September 2026
Sep 15
Form 4Insider transactionPeriod 2026-09-11
Sep 9
Form 4Insider transactionPeriod 2026-09-04
Sep 8
8-KCurrent reportPeriod 2026-09-08
37 more filings + AI summaries on Investor+.INVESTOR